COL015603-hr

Prepare for emerging mutations with an advanced COVID-19 test

Scientists predict that SARS-CoV-2 variants will continue to emerge, as persistent uncontrolled transmission of SARS-CoV-2 in many parts of the world and selective pressures, such as vaccines, are creating ideal conditions for additional, significant virus evolution.

Prepare for the unknown and unexpected with the TaqPath RNase P Combo Kit 2.0—designed with an innovative, multi-target assay design to compensate for current and future emerging SARS-CoV-2 mutations.

 

Features of this kit include:

  • RNase P human sample confirmation
  • Innovative, multi-target design to compensate for emerging mutations
  • Sensitive detection for symptomatic or asymptomatic cases

Fill out the form and read the poster and application note to learn more.

* Required field

*
*
*
*
*
*

Would you like to request a quote or have a Thermo Fisher Scientific representative follow up with you regarding the TaqPath COVID-19 RNase P Combo Kit 2.0? *

 yes
 no
 
 
For Emergency Use Authorization. For in vitro diagnostics. For Prescription use only.